Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride vs Olanzapine for BPSD in Alzheimer's
NCT04341467Unknown
- Sponsor
- Tianjin Anding Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amisulpride in Dementia (2 arms), sponsored by Tianjin Anding Hospital. Primary endpoint: Neuropsychiatric Inventory at 8 weeks. Status: unknown.
02
Drugs
amisulpride
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT04341467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341467.